ESPR

Esperion Therapeutics, Inc.

$3.13 0.00%

Recent alerts on ESPR

All signals →

SEC filing ESPR Stockholders Approve 7M Share Increase to 2022 Stock Option Plan, Elect Directors Carroll and Koenig

News Strength Seen in Aurinia (AUPH): Can Its 5.6% Jump Turn into More Strength?

News Esperion's (ESPR) Drugs Get EU Nod for Lowering Heart Risk

Scanner Large up move: 55.5% (3.7x normal daily movement)

Scanner Large up move: 55.5% (3.8x normal daily movement)

News Key deals this week: Organon, ARC Resources, Nebius, Eli Lilly and more

Scanner Large up move: 55.5% (3.8x normal daily movement)

Scanner Large up move: 55.5% (3.8x normal daily movement)

News Esperion Stock Pops On Billion-Dollar ARCHIMED Buyout

News Esperion jumps on $1.1 billion ARCHIMED buyout

Insider trade Sale by Benjamin Halladay (Chief Financial Officer)

Insider trade Sale by Sheldon L. Koenig (President and CEO)

Insider trade Sale by Benjamin Looker (Chief Legal Officer)

News Esperion outlines Vision 2040 with Corstasis acquisition and targets 2026 operating expenses up to $255M while expanding cardiometabolic portfolio

News Esperion Therapeutics GAAP EPS of $0.22 misses by $0.05, revenue of $168.45M beats by $2.33M

News Esperion Acquires Enbumyst Maker Corstasis

Insider trade Sale by Benjamin Looker

News Top Quant rated bullish small cap stocks among companies with high short interest

News Olatec Therapeutics Presented Preclinical Evidence of Disease-Modifying Activity with Dapansutrile in its Parkinson's Studies

News Espervita's EVT0185 Demonstrates Reversal of Metabolic Dysfunction and Liver Fibrosis in Cell Metabolism Publication

News Esperion Reaches Settlement Agreement with ANDA Filer, Dr. Reddy’s Laboratories, Not to Market Generic Versions of NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) Prior to April 19, 2040

News Esperion Announces Proposed Public Offering of Common Stock

News Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025

News Esperion Appoints Industry Veteran John Harlow as Chief Commercial Officer

Scanner Unusual volume (z=2.8)

Get push alerts for ESPR

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS